Global Blood Fund

“Obi holding company is the sole member of gbf.”

“As the Sole Member of GBF, OBI Holding Company HAS THE AUTHORITY TO APPOINT BOARD MEMBERS.”

“Gbf's form 990 is prepared by an independent accounting firm and reviewed internally prior to distributing to the board. Subsequent to review, all updates are incorporated into the form 990 and are provided to board members prior to filing with the irs.”

“Gbf has a conflict of interest policy that establishes guidelines and procedures applicable to transactions or arrangements that might benefit the private interest of an officer or trustee of the organization. Individuals considering a transaction shall appoint a disinterested person to investigate alternatives to the proposed transaction. If a more advantageous transaction or arrangement is not reasonably attainable under the circumstances that would not give rise to a conflict of interest, the board or committee shall determine, by a majority vote of the disinterested trustees, whether the transaction or arrangement is in the best interest of the organization and whether the transaction is fair to the organization. Each trustee, officer, and member of a committee with board delegated powers shall annually sign a statement which affirms that such a person has received a copy of the conflict of interest policy, has read and understands the policy, has agreed to comply with the policy and understands that the organization is a charitable organization and that in order to maintain its federal tax exemption, it must engage primarily in activities which accomplish one or more of its tax-exempt purposes. If the board or the committee has reasonable cause to believe that an interested person has failed to disclose a conflict of interest as required by this policy, the board or committee shall inquire, investigate and take appropriate disciplinary and corrective action, as necessary.”

“The volunteer board members and officers are compensated by a related organization. No part of the related entity compensation is for services rendered to the filing organization. The executive compensation for those individuals is paid by a related organization (oklahoma blood institute -"obi") of gbf's sole corporate member. The obi policy is as follows: as leaders of the state's largest biopharmaceutical organization, a 900-plus staff entity, the roles of ceo and other physicians and executives require a rare blend of astute organizational leadership, vision, fiduciary management, advanced medical specialization and expertise in the unique scientific field of transfusion medicine. Executives have responsibility for fifteen operational facilities across three states and ten major markets in the region and the day-to-day provision of a safe and sufficient blood supply to meet the needs of patients in more than 212 facilities served. The compensation of the ceo is determined by the executive committee of the board of directors comprising community leaders, business executives and physicians with exemplary ethical and fiduciary standards. Ceo compensation is based on comparative salary data from similar health care organizations using irs form 990s and industry salary surveys. Similarly, compensation for executives reporting to the ceo is proposed by the ceo based on comparable national and local salaries for positions and approved by the executive committee. Changes to compensation are reviewed and formally approved annually by the executive committee of the related organization's board of directors. Gbf's contract executive director is an independent contractor. His compensation is reviewed and approved by the board.”

“The governing documents, conflict of interest policy, and financial statements are made available upon request.”

“(Expenses $ 18,118 including grants of $ 4,378) MUCH OF GBF'S ACTIVITY RELATES TO ITS ABILITY TO CREATE AND GALVANIZE NETWORKS IN THE US, EUROPE, AND AUSTRALASIA (NATIONAL AND REGIONAL BLOOD SERVICES, INDUSTRY SUPPLIERS, REGULATORY BODIES ETC.) TO ASSIST DEVELOPING-WORLD BLOOD COLLECTION ORGANIZATIONS. WORKING BOTH DIRECTLY AND THROUGH PAN-NATIONAL AND PROFESSIONAL ASSOCIATIONS, GBF IS ABLE TO ASSEMBLE MULTI-AGENCY COLLABORATIONS, WITH OBJECTIVES AND CONFIGURATIONS DIFFERING BY PROJECT. OVER THE PERIOD, CLOSE RELATIONSHIPS WERE NURTURED WITH ASBT (AFRICA SOCIETY FOR BLOOD TRANSFUSION), ISBT (INTERNATIONAL SOCIETY FOR BLOOD TRANSFUSION), COBA (COALITION OF BLOOD FOR AFRICA), AABB (ASSOCIATION FOR THE ADVANCEMENT OF BLOOD AND BIOTHERAPIES), ADRP (ASSOCIATION OF BLOOD DONOR PROFESSIONALS), GCIAMT (GRUPO COOPERATIVO IBEROAMERICANO DE MEDICINA TRANSFUSIONAL), ETC. A FORMAL MEMORANDUM OF UNDERSTAND WAS SIGNED WITH GCIAMT TO REFLECT GBF'S INCREASED FOCUS ON THE LATIN AMERICA REGION. GBF ALSO PARTNERED WITH A FRENCH MANUFACTURER OF ABO/RH TESTING TECHNOLOGY, DIAGAST, TO SUPPORT A PILOT IN GHANA OF PRE-DONATION BLOOD TYPING AS A RECRUITMENT STRATEGY.”

“(Expenses $ 9,059 including grants of $ 2,188) GBF'S "OPEN ARMS" PROGRAM GIVES BLOOD CENTERS ACROSS THE U.S. AND IN OTHER PARTS OF THE WORLD AN OPPORTUNITY TO OFFER THEIR BLOOD DONORS A CHARITABLE ALTERNATIVE TO THE USUAL RECOGNITION ITEMS OF PRINTED T-SHIRTS, ETC. THIS PROGRAM CREATES A VIRTUOUS CIRCLE OF ACTIVITY SUCH AS IMPROVING DONOR CHOICE, MOTIVATING COLLECTION STAFF, SAVING BLOOD CENTERS MONEY, PROVIDING A DIVERSITY PLATFORM TO ENCOURAGE BLOOD DONATION FROM MINORITY COMMUNITIES AND PROVIDING RESOURCES FOR INTERNATIONAL DEVELOPMENT WORK IN AN AREA OF INTEREST TO ALL PARTIES. HOWEVER, BLOOD COLLECTORS ARE INCREASING LOOKING TO RAISE CHARITABLE FUNDS TO RESOURCE THEIR OWN CORE-MISSION, LEADING TO A REDUCTION IN THE WILLINGNESS TO ENCOURAGE THEIR DONORS AND OTHER STAKEHOLDERS TO GIVE TO THIRD-PARTY ORGANIZATIONS, HOWEVER RELEVANT THE CAUSE. IN RESPONSE, GBF HAS SWITCHED ITS STRATEGY AWAY FROM, FOR EXAMPLE, A PASSIVE BRANDED PRESENCE IN POINT-REDEMPTION STORES, TO INSTEAD OFFER TACTICAL SUPPORT ON A CAUSE-SPECIFIC BASIS THAT WILL ENGAGE BLOOD DONORS AND THEREBY IMPROVE COLLECTION, OR DELIVER AGAINST SOME OTHER SPECIFIC BUISNESS OBJECTIVE. SUPPORT FOR UKRAINE WAS A SUCCESSFUL EXAMPLE OF THIS APPROACH, THOUGH THE SALIENCE OF THIS CAUSE WANED DURING 2023.”